Clinical Trials Logo

Small Intestinal Neoplasms clinical trials

View clinical trials related to Small Intestinal Neoplasms.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03817866 Completed - Clinical trials for Colorectal Neoplasms

Chromogranin A as Blood Marker in Cancer Patients

Start date: January 29, 2019
Phase:
Study type: Observational

Gastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and pancreas. They account for 50-70% of all incident NETs. Due to the lack of symptoms in the early stage of disease and the frequency of nonspecific GI symptoms, GEP-NETs are difficult to diagnose. Identification of effective biomarkers (such as Chromogranin A) to improve GEP-NET diagnosis, as well as to assess treatment efficacy, relapse and prognosis, is important for improving outcomes for patients with GEP-NETs. The purpose of this study is to validate the performance of Brahms (BRAHMS) Chromogranin A II Kryptor (KRYPTOR) assay to monitor the course of disease in patients with well-defined GEP-NETs.